NOV 08, 2018 3:54 PM PST

What Cannabis Can Do

WRITTEN BY: Ilene Schneider

Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body's cells do not respond properly to insulin, or both. In 2013 it was estimated that more than 382 million people in the world had some form of diabetes.
Israeli researchers are working on ways to use cannabis receptors to provide diabetes medication.
Israeli scientists are testing a cannabis-based therapy for diabetes. Researchers at the Hebrew University of Jerusalem have tracked down a specific chemical compound in the cannabis plant, a cannabinoid called "cannabidiol" that researchers say can be used to treat diabetes. The best source for cannabidiol, or CBD, is hemp.

Dr. Raphael Mechoulam, the researcher known for discovering CBD, has collaborated with researcher Dr. Ruth Gallily, also from Hebrew University. Dr. Mechoulam discovered receptors for cannabinoids in the brain and in other body tissues, opening up an entirely new area of research into how coucannabinoids could be modified to fit different receptors to treat different illnesses.

Meanwhile, the discovery is already becoming a marketable commodity. An Israeli company called ISA Scientific signed a worldwide collaboration and licensing deal with Yissum, the technology-transfer company of Hebrew University; Hadasit, the technology-transfer company of Hadassah Medical Organization of Jerusalem; and KIR, the Kennedy Trust for Rheumatology Research in the UK.

The deal enables the creation and development of specific therapies using cannabidiol (CBD) by the inter-disciplinary research team headed by Mechoulam. KIR director/immunologist Sir Marc Feldman is also involved in the effort, as are Hadassah researchers and physicians Chaim Lotan, Lolan Weiss and Ronen Durst.

There are Phase I clinical trials on dosing and safety underway in Israel, according to ISA Scientific CEO Mark J. Rosenfeld. "Arrangements for Phase 2 trials on treating diabetes and chronic pain are in process," he said in a statement.

As Rosenfeld explained, the firm's Israeli research and development team had been working on the issue of an oral delivery system. Because very little CBD reaches the bloodstream when taken by mouth, it is necessary to create a more efficient system, he said. The problem was solved "with proprietary nanotechnology" currently being integrated into the firm's clinical trials.

According to Rosenfeld, CBD seems to have no major side effects. It does not affect activities such as work, school, sports or driving. In addition, the company said that it is working towards creating a way to "control diabetes into the medical market place."

"CBD may even help prevent diabetes," Rosenfeld said.

Sources: Holistic Primary Care, Mayo Clinic

About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAY 27, 2021
Neuroscience
Research Less Likely to Be True is Cited More
MAY 27, 2021
Research Less Likely to Be True is Cited More
Researchers from the University of California San Diego have found that non-replicable data is cited 153 times more ofte ...
JUL 08, 2021
Cannabis Sciences
High-potency Cannabis Impacts Memory, but not Decision-Making
JUL 08, 2021
High-potency Cannabis Impacts Memory, but not Decision-Making
High-potency cannabis products impair memory in various ways, according to new research published in Scientific Rep ...
JUL 08, 2021
Health & Medicine
Past Cannabis Use No Longer Barrier to Joining FBI
JUL 08, 2021
Past Cannabis Use No Longer Barrier to Joining FBI
Without trumpet or fanfare, the hard line recruitment policy the FBI had held around cannabis use has been changed to be ...
JUL 15, 2021
Health & Medicine
The Effect of Cannabis Dispensary Density on Young People's Cannabis Use
JUL 15, 2021
The Effect of Cannabis Dispensary Density on Young People's Cannabis Use
As cannabis dispensaries have sprung up in legal states all around the USA, there has been little analysis of their impa ...
JUL 29, 2021
Health & Medicine
CBD Linked WIth Better Quality of Life in Epilepsy Patients
JUL 29, 2021
CBD Linked WIth Better Quality of Life in Epilepsy Patients
People with epilepsy report better well-being when they self-medicate with cannabidiol (CBD) according to a new study pu ...
AUG 11, 2021
Health & Medicine
Cannabis Users Are Normal Hardworking Members of the Community Too
AUG 11, 2021
Cannabis Users Are Normal Hardworking Members of the Community Too
  Who is the typical cannabis user? There are many stereotypes and misconception about weed use, most of them not f ...
Loading Comments...